• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫混合性中胚叶肿瘤

Mixed mesodermal tumors of the uterus.

作者信息

Afonso J F

出版信息

West J Med. 1974 Jan;120(1):17-26.

PMID:4359847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1129297/
Abstract

Two of five women with mixed mesodermal tumor of the uterus are well more than ten years after therapy. A third was well when last seen two years after therapy and died at age 84 but autopsy was not done. Review of the literature and the reported experience indicates that this diagnosis should be suspected more often. Since histologic features may vary from one place to another within the lesion, accurate assessment requires examination of adequate specimens of the tumor. The mere presence of heterologous elements in an endometrial carcinoma changes the five-year survival rate from 85 percent to less than 35 percent. While total abdominal hysterectomy with bilateral salpingo-oophorectomy is mandatory, radiation therapy should be added more often than in the past, as it has been clearly shown that many of these tumors are radiosensitive.

摘要

患有子宫混合性中胚叶肿瘤的五名女性中有两名在接受治疗后健康存活超过十年。第三名女性在治疗后两年最后一次被见到时情况良好,84岁时去世,但未进行尸检。文献回顾和报告的经验表明,这种诊断应更频繁地被怀疑。由于病变内不同部位的组织学特征可能有所不同,准确评估需要检查足够的肿瘤标本。子宫内膜癌中单纯存在异源性成分会使五年生存率从85%降至不到35%。虽然全腹子宫切除加双侧输卵管卵巢切除是必要的,但放疗应比过去更频繁地添加,因为已经清楚表明这些肿瘤中的许多对放疗敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d168/1129297/9764399fe271/westjmed00305-0045-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d168/1129297/2dc00217f83e/westjmed00305-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d168/1129297/9764399fe271/westjmed00305-0045-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d168/1129297/2dc00217f83e/westjmed00305-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d168/1129297/9764399fe271/westjmed00305-0045-b.jpg

相似文献

1
Mixed mesodermal tumors of the uterus.子宫混合性中胚叶肿瘤
West J Med. 1974 Jan;120(1):17-26.
2
Mixed mesodermal tumor of the uterine body: relationship between histology and survival.子宫体混合性中胚叶肿瘤:组织学与生存率的关系。
Gan. 1976 Apr;67(2):263-73.
3
Mixed müllerian tumors of the uterus: a clinicopathologic study.子宫混合性苗勒管肿瘤:一项临床病理研究。
Obstet Gynecol. 1989 Sep;74(3 Pt 1):388-92.
4
Malignant mixed müllerian tumors of the uterus. A clinicopathologic assessment of 34 cases.子宫恶性苗勒管混合瘤。34例临床病理评估
Am J Surg Pathol. 1979 Apr;3(2):125-35. doi: 10.1097/00000478-197904000-00003.
5
Prognostic features of sarcomas and mixed tumors of the endometrium.
Obstet Gynecol. 1984 Apr;63(4):550-6.
6
A case report of mixed mesodermal tumor of the uterine cervix (mixed, heterologous and homologous sarcoma of the uterine cervix).一例子宫颈混合性中胚层肿瘤(子宫颈混合性、异源性和同源性肉瘤)病例报告
Jpn J Clin Oncol. 1986 Dec;16(4):391-6.
7
Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus.子宫恶性中胚叶(苗勒氏)混合瘤的预后因素
Gynecol Oncol. 1985 Jan;20(1):32-42. doi: 10.1016/0090-8258(85)90122-2.
8
[Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].[子宫恶性中胚叶混合瘤——37例研究]
Zhonghua Zhong Liu Za Zhi. 1991 Sep;13(5):378-80.
9
Mixed mesodermal tumors.混合性中胚层肿瘤
Am J Obstet Gynecol. 1969 Jul 1;104(5):693-8. doi: 10.1016/0002-9378(69)90609-7.
10
Management of malignant, mixed mesodermal tumors of the uterus.子宫恶性混合性中胚叶肿瘤的管理
Gynecol Oncol. 1989 Feb;32(2):240-4. doi: 10.1016/s0090-8258(89)80041-1.

引用本文的文献

1
Clinical Profile and Treatment Outcomes of Malignant Mixed Mullerian Tumors of the Uterus: A Single-Center Experience.子宫恶性混合性苗勒管肿瘤的临床特征与治疗结果:单中心经验
Cureus. 2023 Oct 31;15(10):e48079. doi: 10.7759/cureus.48079. eCollection 2023 Oct.
2
Renal Hemangioblastoma with Mixed Mullerian tumour of endometrium: A tale of two rare primary tumours.肾血管母细胞瘤合并子宫内膜混合性苗勒管肿瘤:两种罕见原发性肿瘤的故事
World J Surg Oncol. 2020 Jul 6;18(1):154. doi: 10.1186/s12957-020-01929-1.
3
A Comparative Review of Mixed Mammary Tumors in Mammals.

本文引用的文献

1
Mesodermal mixed tumor of the corpus uteri.子宫体中胚叶混合瘤
Am J Obstet Gynecol. 1952 Mar;63(3):605-12. doi: 10.1016/0002-9378(52)90075-6.
2
Cultural characteristics of three granular-cell myoblastomas.三例颗粒细胞成肌细胞瘤的组织学特征
Cancer. 1951 Jul;4(4):857-65. doi: 10.1002/1097-0142(195107)4:4<857::aid-cncr2820040423>3.0.co;2-g.
3
Combined mesenchymal sarcoma and carcinoma (carcinosarcoma) of the uterus.子宫混合性间叶肉瘤和癌(癌肉瘤)
哺乳动物混合性乳腺肿瘤的比较研究
J Mammary Gland Biol Neoplasia. 2019 Jun;24(2):125-137. doi: 10.1007/s10911-018-9422-2. Epub 2018 Nov 28.
4
Malignant mixed Mullerian tumour of the uterus.子宫恶性苗勒管混合瘤
Ecancermedicalscience. 2013 Apr 4;7:302. doi: 10.3332/ecancer.2013.302. Print 2013.
5
[Heterologous Müllerian adenosarcoma of the uterus--a rare tumor. Light- and electron-microscopic findings, biological behavior (author's transl)].
Arch Gynecol. 1981;231(1):75-85. doi: 10.1007/BF02110027.
Cancer. 1951 Jul;4(4):803-16. doi: 10.1002/1097-0142(195107)4:4<803::aid-cncr2820040417>3.0.co;2-m.
4
Malignant mixed mesodermal tumor of the uterus. Report of a case.
Obstet Gynecol. 1961 Dec;18:757-62.
5
Uterine sarcomas: histogenesis and taxonomy.子宫肉瘤:组织发生与分类学
Ann N Y Acad Sci. 1959 Jan 9;75:568-85. doi: 10.1111/j.1749-6632.1959.tb44576.x.
6
MESODERMAL MIXED TUMOR OF THE CORPUS UTERI. REVIEW AND REPORT OF SIX CASES, ONE OF WHICH HAS SURVIVED FIFTEEN YEARS.子宫体中胚层混合瘤。六例病例回顾及报告,其中一例存活十五年。
Am J Obstet Gynecol. 1964 Oct 15;90:450-9.
7
Cure of primary mesodermal mixed tumor by radiotherapy.放射治疗治愈原发性中胚层混合瘤。
Obstet Gynecol. 1962 Apr;19:537-41.
8
Similarities in malignant mixed mesenchymal tumors of the endometrium.子宫内膜恶性混合性间叶肿瘤的相似性。
Obstet Gynecol Surv. 1962 Feb;17:1-18. doi: 10.1097/00006254-196202000-00001.
9
Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus.子宫癌肉瘤(恶性中胚叶混合瘤)
Am J Clin Pathol. 1963 May;39:496-505. doi: 10.1093/ajcp/39.5.496.
10
Uterine mesodermal mixed tumors.
Am J Obstet Gynecol. 1960 Aug;80:368-73. doi: 10.1016/0002-9378(60)90140-x.